Damien Ricard
Clamart, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 120 publications
Early serum S100β but not neuron-specific enolase reflects baseline CNS vulnerability in ICANS after CD19 CAR T-cell therapy.
Journal: Journal of neurology
Published: January 05, 2026
Stride-level measurement of gait as an early sensitive marker of disability progression in ambulatory patients with multiple sclerosis.
Journal: EClinicalMedicine
Published: September 26, 2025
Impact of sensory afferences in postural control quantified by force platform in healthy older adults: Systematic review and meta-analysis.
Journal: Experimental gerontology
Published: July 27, 2025
Early onset radiation-induced leukoencephalopathy in patients treated for a glioblastoma by STUPP protocol and risk factors evaluation, an ancillary study of the phase III ASTER protocol.
Journal: Revue neurologique
Published: May 29, 2025
Specific radiosensitivity of brain structures (areas or regions) and cognitive impairment after focal or whole brain radiotherapy: A review.
Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Published: March 12, 2025
Bevacizumab for Radiation-Induced (Radiculo)plexopathy.
Journal: European journal of neurology
Published: February 26, 2025
A french version of the OSU TBI-ID for screening TBI in PTSD Military personnel.
Journal: L'Encephale
Published: January 24, 2025
Real-world gait study of Parkinson's disease using wearable sensors: a systematic review.
Journal: Journal of neuroengineering and rehabilitation
Published: October 21, 2024
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 02, 2024
Proton therapy versus conventional radiotherapy for the treatment of cavernous sinus benign meningioma, a randomized controlled phase III study protocol (COG-PROTON-01).
Journal: BMC cancer
Published: June 02, 2024
Last Updated: 09/26/2026